DRVN vs DRMAW: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

DRVN has stronger fundamentals based on our AI analysis.

DRVN
Driven Brands Holdings Inc.
HOLD
62%
Confidence
VS
DRMAW
Dermata Therapeutics, Inc.
STRONG SELL
92%
Confidence

DRVN vs DRMAW Fundamental Comparison

Metric DRVN DRMAW
Revenue $1.6B $161,357.0
Net Income $89.3M $-5.7M
Net Margin 5.6% -3,530.5%
ROE 11.3% -143.9%
ROA 2.2% -112.3%
Current Ratio 0.90x 7.66x
Debt/Equity 2.44x 0.00x
EPS $0.69 $-6.64

Green = Better metric | Red = Weaker metric

View Full DRVN Analysis →
View Full DRMAW Analysis →

You Might Also Compare

DRVN vs AAPL DRMAW vs MSFT DRVN vs GOOGL DRMAW vs AMZN

DRVN vs DRMAW: Frequently Asked Questions

Is DRVN or DRMAW a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), DRVN has stronger fundamentals. DRVN is rated HOLD (62% confidence) while DRMAW is rated STRONG SELL (92% confidence). This is not investment advice.

How does DRVN compare to DRMAW fundamentally?

Driven Brands Holdings Inc. has ROE of 11.3% vs Dermata Therapeutics, Inc.'s -143.9%. Net margins are 5.6% vs -3,530.5% respectively.

Which stock pays higher dividends, DRVN or DRMAW?

DRVN has a dividend yield of N/A or no dividend while DRMAW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in DRVN or DRMAW for long term?

For long-term investing, consider that DRVN has HOLD rating with 62% confidence, while DRMAW has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about DRVN vs DRMAW?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For DRVN vs DRMAW, the AI consensus favors DRVN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.